STRS Ohio’s SpringWorks Therapeutics SWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-21,700
Closed -$958K 2301
2025
Q1
$958K Buy
+21,700
New +$999K ﹤0.01% 890
2024
Q4
Sell
-5,000
Closed -$160K 2046
2024
Q3
$160K Hold
5,000
﹤0.01% 1618
2024
Q2
$188K Buy
5,000
+400
+9% +$16.8K ﹤0.01% 1575
2024
Q1
$226K Buy
4,600
+1,800
+64% +$83.2K ﹤0.01% 1520
2023
Q4
$102K Buy
+2,800
New +$73.1K ﹤0.01% 1693
2022
Q4
Sell
-15,600
Closed -$445K 2065
2022
Q3
$445K Hold
15,600
﹤0.01% 1372
2022
Q2
$384K Buy
15,600
+900
+6% +$32.9K ﹤0.01% 1437
2022
Q1
$829K Hold
14,700
﹤0.01% 1151
2021
Q4
$911K Hold
14,700
﹤0.01% 1177
2021
Q3
$932K Sell
14,700
-300
-2% -$23.1K ﹤0.01% 1145
2021
Q2
$1.24M Buy
15,000
+1,300
+9% +$98.7K ﹤0.01% 1030
2021
Q1
$1.01M Hold
13,700
﹤0.01% 1166
2020
Q4
$993K Sell
13,700
-2,700
-16% -$174K ﹤0.01% 1066
2020
Q3
$781K Buy
16,400
+11,000
+204% +$468K ﹤0.01% 1064
2020
Q2
$226K Buy
5,400
+2,700
+100% +$96.1K ﹤0.01% 1607
2020
Q1
$72K Hold
2,700
﹤0.01% 1734
2019
Q4
$103K Buy
+2,700
New +$63.2K ﹤0.01% 1779

Other funds holding SWTX

STRS Ohio's SWTX Position: Q2 2025 in Review

STRS Ohio sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 21,700 shares — an estimated $958K sold.

STRS Ohio first reported a position in SWTX in Q4 2019 and held it in 17 quarters. The position peaked at $1.24M in Q2 2021. 223 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.

  • STRS Ohio reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
  • STRS Ohio sold 21,700 SpringWorks Therapeutics shares in Q2 2025, an estimated $958K.
  • STRS Ohio first reported a position in SpringWorks Therapeutics in Q4 2019 and held it in 17 quarters.
  • STRS Ohio's SpringWorks Therapeutics position peaked at $1.24M in Q2 2021.
  • 223 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.

Based on STRS Ohio's 13F filing for Q2 2025, filed 4 Aug 2025.